Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel L-glutamic acid route for multi-chiral tetrahydrofuran rings. High stereoselectivity and mild conditions for cost-effective API manufacturing.
Patented chloroform-based route for o-chloromandelic acid ensures high purity and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN104693020A details a high-purity synthesis route for Cinacalcet intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105348279B reveals optimized synthesis for Aclidinium bromide intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN1373116A reveals a novel resolution method for agrochemical intermediates, offering significant cost reduction and supply chain reliability for pyrethroid manufacturers globally.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Patent CN103387494A reveals a novel amine-mediated demethylation route for 2-hydroxy-4,5-dimethoxybenzoic acid, offering significant cost reduction and safer manufacturing for Acotiamide intermediates.
Patent CN106905177A details high-yield synthesis for AHU-377 intermediate. Offers cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Novel patent CN113880704B offers high-purity 18O-labeled aldehydes. Reduces heavy oxygen water loss and simplifies scale-up for pharmaceutical intermediates manufacturing globally.
Patent CN114085152A reveals a green, high-yield route for 2-(4-nitrophenyl)butyric acid, eliminating nitration isomers for cost-effective API manufacturing.
Patent CN112851508A details a safe, scalable route to 3,4-difluoro-2-methylbenzoic acid, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108264469B reveals a novel catalytic cyclization route for 2-(cyclohexenylene) malonic acid derivatives, offering high yields and cost reduction in herbicide intermediate manufacturing.
Patent CN102093247B reveals a novel silver-mediated acylation route for Tolvaptan intermediates, offering safer conditions and high purity compared to traditional palladium methods.
Novel route for GABA-T inhibitor precursor via lactam rearrangement offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN113072456A details a novel copper-catalyzed asymmetric difluoromethylation for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN107988307A details enzymatic resolution for high-purity intermediates. This method offers significant supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN115181031A reveals a low-cost chlorination route for chlorantraniliprole intermediates using sulfuryl chloride, offering high purity and scalable manufacturing.
Patent CN115651049A details a synthetic route for Cholic Acid Intermediate A3, offering a virus-free alternative to animal extraction for reliable pharmaceutical supply chains.
Novel industrial route for 2,4,5-trifluorophenylacetic acid using 2,4-dichlorotoluene. High yield, cost-effective manufacturing for DPP-4 inhibitor intermediates.